Company News »

Company Profile for Quintiles

Business Wire
Share on StockTwits
Published on

Quintiles, a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 30,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market.

Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes.

At Quintiles, we improve customers’ probability of success by connecting insights with superior delivery.

This is our way of working together differently to shape ideas, execute effectively and share success. Today, Quintiles brings a fully integrated approach to build biopharma and life sciences solutions — from pipeline through portfolio to population health. The goals customers set define the work we do and the standards we work to achieve.

PRODUCT DEVELOPMENT

Our Product Development group enables biopharmaceutical companies, including medical device companies and diagnostics companies, to outsource clinical development, from first-in-human studies to post-launch monitoring.

Our comprehensive services provide scientific and analytical expertise, global access, best in class technology, and local and global regulatory expertise at each stage of development to help our customers improve product development efficiency and effectiveness. Product Development is comprised Clinical solutions and services include project management and clinical monitoring functions for conducting multi-site trials (generally Phase II-IV), collectively known as “core clinical.”

Our global laboratories, data management, biostatistics, safety and pharmacovigilance, early clinical development (generally Phase I), and strategic planning and design services enable us to provide end-to-end solutions to our customers. Consulting provides strategy and management consulting services based on life science expertise and advanced analytics, as well as regulatory and compliance consulting services.

INTEGRATED HEALTHCARE SERVICES (IHS)

Quintiles’ Integrated Healthcare Services (IHS) address the outsourced commercial needs of biopharmaceutical customers as well as the needs of the broader healthcare sector for value-based analyses, research studies and evidence-based medicine.

Service offerings include commercial services such as sales representatives, strategy, market access, marketing communications and other areas related to commercialization.

Outcomes research including drug therapy analysis, real-world research and evidence-based medicine, including research studies to prove a drug’s value are also part of our IHS offering along with comparative and cost-effectiveness research, clinical management analytics, decision support services, medication adherence and health outcome optimization services, and web-based systems for measuring quality improvement.

Company:

Quintiles

Headquarters Address:

4820 Emperor Boulevard
Durham, NC 27703

Main Telephone:

919.998.2000

Website:

www.Quintiles.com

Ticker/ISIN:

Q(NYSE)/US74876Y1010

Type of Organization:

Public

Industry:

Pharmaceutical

Key Executives:

CEO: Tom Pike

CFO: Kevin Gordon

Public Relations

Contact:

Phil Bridges

Phone:

919.998.1653

Email:

phil.bridges@quintiles.com

Public Relations

Contact:

Mari Mansfield

Phone:

919.998.2639

Email:

mari.mansfield@quintiles.com

Investor Relations

Contact:

Karl Deonanan

Phone:

919.998.2789

Email:

InvestorRelations@quintiles.com

Share on StockTwits


Iron FX 1.11156/1.11128 2.8
XM Markets 1.09948/1.09928 2
FxPro 1.10184/1.10171 1.3
FXCM 1.13943/1.13912 3.1